...BRCA2. The particular sensitivity of sarcoma, ovarian and breast cancer cells deficient in HRR, previously observed in p...
...BRCA2 mutations account for about 10% of all MBC cases. Thus, a fraction of MBC cases are expected to be due to genetic ...
...BRCA2 genes. We also observed that the addition of only few clinical data was sufficient to obtain a more stable classif...
...BRCA2, have been identified. However, mutations in these genes account for only 5-10% of identified breast cancer cases....
...BRCA2 genes results in an elevated risk for developing both breast and ovarian cancers over the lifetime of affected car...
...BRCA2, FANCC and FANCD2 were analyzed in pretherapeutic/neoadjuvant chemotherapy (NACT)-treated BC samples.,Alterations ...
...BRCA2. Among 15 candidates genotyped in healthy controls, c.5339T>C in BRCA1 and c.6029T>G, c.7522G>A in BRCA2 were not ...
...BRCA2 mutation carriers, precursor lesions were only detected in those older than 40 years of age, indicating the possib...
...BRCA2 and to explore its functional roles in EC. A yeast two-hybrid screening was performed to identify a novel BRCA2-in...
...BRCA2 mutations. However, it is becoming increasingly evident that tumors that share molecular features with BRCA-mutant...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
